All News about Vaxcyte Inc![]()
Vaxcyte to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From Vaxcyte, Inc.
Via Globe NewsWire
![]() ![]() Via Benzinga
![]() ![]() ![]() From Vaxcyte, Inc.
Via Globe NewsWire
![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Via Benzinga
![]()
Vaxcyte to Present at Upcoming Investor Conferences
November 03, 2022
From Vaxcyte, Inc.
Via Globe NewsWire
![]() ![]() ![]() ![]()
Vaxcyte Announces Pricing of $600 Million Public Offering
October 26, 2022
From Vaxcyte, Inc.
Via Globe NewsWire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|